About Seqens

SEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong industrial network, 10 R&D centers and 3,500 employees in 9 countries. As an integrated player across the value chain - from raw materials to active ingredients and from research and development to industrialization - SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients, develops and industrializes the most demanding molecules, and relies on its ability to innovate and implement the best available technologies.

  • FR
  • 2017
    On CPHI since
  • 4
  • 1000 - 4999
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Generic APIs producer
Intermediates Manufacturer
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Seqens (5)

  • Active Pharmaceutical Ingredients

    Product Active Pharmaceutical Ingredients

    SEQENS CDMO is a global leader on the production of Active Pharmaceutical Ingredients. The company has over 25 years of experience in developing and producing high-quality Active Pharmaceutical Ingredients using first class R&D and proprietary technology such as biocatalysis to develop unique proces...
  • Custom Development & Manufacturing

    Product Custom Development & Manufacturing

    Contract Research & Manufacturing Services:Full service from Preclinical to Industrial API Production
  • Drug Delivery Solutions

    Product Drug Delivery Solutions

  • Paracetamol

    Product Paracetamol

    SEQENS offers wide range of products which includes paracetamol. Contact us for more information.
  • Expansorb

    Product Expansorb

    Poly(lactic acid co-glycolic acid) and poly(caprolactone) copolymers used as functional excipients for controlled and slow drug release (weeks to months) with a single injection.

Seqens Resources (10)